Skip to content

A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy

A RCT Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04422249
Enrollment
95
Registered
2020-06-09
Start date
2019-12-23
Completion date
2023-12-23
Last updated
2023-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

Laparoscopic Middle hepatic vein Hepatocellular carcinoma

Brief summary

The study, entitled RCT study of laparoscopic middle hepatic venous guidance versus conventional ananatomical hemihepatectomy, was designed to compare the efficacy of two different ananatomical hemihepatectomy procedures under laparoscopy.

Detailed description

Backgroud & Aim:Hepatectomy is the main way to treat all kinds of liver surgical diseases, which can be divided into anatomic hepatectomy and non-anatomic hepatectomy.Among them, anatomic hepatectomy is suitable for primary liver cancer, hepatolithiasis and other benign and malignant diseases;It can be divided into hepatic venous guidance and non-hepatic venous guidance hepatectomy (traditional ananatomical hepatectomy).The aim of this study was to observe and compare the perioperative period and follow-up results of the two different laparoscopic surgical resection methods, and to provide high-level evidence-based medicine evidence for the selection of surgical methods for laparoscopic anatomical hemihepatectomy.

Interventions

PROCEDURElaparoscopic middle hepatic vein guidance anatomic hemihepatectomy

95 patients with primary HCC were divided into the middle hepatic vein guidance group(n=45) and the traditional group(n=45) according to the odd and even Numbers, and sealed into envelopes.Outcomes were monitored and evaluated during the 3-year follow-up period

Sponsors

Southwest Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Two different treatments are conducted on the participant base on the randomized choices

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. the site was limited to the patients who were suitable for dissecting hemihepatectomy; 2. the type of disease was limited to hepatocellular carcinoma; 3. the patients were generally able to tolerate anesthesia, the liver reserve function was good, and the patients were suitable for laparoscopic surgery; 4. child-pugh grade A, no severe liver cirrhosis, portal hypertension, no extrahepatic and extrahepatic metastasis and main vascular invasion; 5. the subjects who participated in this study indicated that they were willing to accept the two surgical methods and agreed to be randomly divided into groups during the operation; 6. 18 ≤ age ≤ 70, male or female.

Exclusion criteria

1. preoperative liver function Child-pugh grade B or C; 2. patients with poor general condition and could not tolerate pneumoperitoneum or anesthesia; 3. patients with severe liver cirrhosis, portal hypertension and lesions invading liver porta; 4. patients with other treatment methods such as radio frequency ablation in addition to dissecting hepatectomy; 5. repeated abdominal operations resulting in severe abdominal adhesion, unable to perform laparoscopic hepatectomy; male and female are not limited

Design outcomes

Primary

MeasureTime frameDescription
Survival rate3 yearsfollow-up after the surgery every 3 months, to understand statistics 1-year overall survival、3-year overall survival、1-year disease-free survival、3-year disease-free survival

Secondary

MeasureTime frameDescription
Perioperative resultsDuration perioperation(an expected average of 3 days)the angle of hepatic vein between segment Ⅳ b and Ⅴ, angle between MHV and IVC
intraoperative parametersduring the operationblood loss per unit area will be combined to report intraoperative parameters in milliliter/square centimetre(ml/c㎡)

Other

MeasureTime frameDescription
Incidence of postoperative complicationsDuration hospitalization(an expected average of 7 days)hemorrhage,biliary leakage,ascites,intra-abdominal infection,pleural effusion,pulmonary infection,cardiopulmonary insufficiency,liver function failure

Countries

China

Contacts

Primary ContactShuguo Zheng, M.D.
shuguozh@yahoo.com.cn0086-13508308676
Backup ContactShuguo Zheng, Zheng
shuguozh@yahoo.com.cn0086-13508308676

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026